Anafilaksja – ważny problem w alergologii
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2011
Słowa kluczowe:
anafilaksja, patomechanizm
##plugins.themes.bootstrap3.article.main##
Abstrakt
Anafilaksja należy do najgroźniejszych chorób alergicznych. Prawidłowe i wczesne jej rozpoznanie pozwala na wdrożenie leczenia, które może zapobiec rozwojowi wstrząsu anafilaktycznego. W pracy omówiono przyczyny, rozwój i przebieg oraz zasady zapobiegania anafilaksji.
Pobrania
Dane pobrania nie są jeszcze dostepne
##plugins.themes.bootstrap3.article.details##
Jak cytować
Gawlik , R., & Wróbel-Rajzer , M. (2011). Anafilaksja – ważny problem w alergologii. Alergoprofil, 7(3), 15-20. Pobrano z https://journalsmededu.pl/index.php/alergoprofil/article/view/278
Numer
Dział
Artykuł
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
Bibliografia
1. International Collaborative Study of Severe Anaphylaxis: An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 1998, 9: 141-146.
2. Yocum M.W., Butterfield J.H., Klein J.S. et al.: Epidemiology of anaphylaxis in Olmsted County: a population-based study. J. Allergy Clin. Immunol. 1999, 104: 452-456.
3. Lieberman P., Camargo C.A. Jr, Bohlke K., Jick H., Miller R.L., Sheikh A. et al.: Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann. Allergy Asthma Immunol. 2006, 97: 596-602.
4. Ewan P.: Anaphylaxis. BML 1996, 1998: 1442-1445, Wasserman S.I.: Anaphylaxis. Kaplan A.P.: Allergy. W.B. Saunders Comp. New York 1997: 565-572.
5. Mertes P.M., Laxenaire M.C., Alla F.: Groupe d’Etudes des Reactions Anaphylactoides Peranesthesiques: Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003, 99: 536-545.
6. Moss J.: Allergic to anesthetics. Anesthesiology 2003, 99: 521-523.
7. Graft D.F., Schuberth K.C., Kagey-Sobotka A. et al.: A prospective study of the natural history of large local reactions after Hymenoptera stings in children. J. Pediatr. 1984, 104: 664-668.
8. Müller U.R.: Insect sting allergy: clinical picture, diagnosis and treatment. Gustav Fischer Verlag, Stuttgart 1990.
9. Lieberman P.L.: Anaphylactoid reactions to radiocontrast material. Immunol. Allergy Clin. North. Am. 1992, 12: 649-652.
10. Ring J., Behrend H.: Anaphylaxis and anaphylactoid reactions: classification and pathophysiology. Clin. Rev. Allergy. Immunol. 1999, 17: 387-399.
11. Johansson S.G.O., Bieber T., Dahl R. et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 2004, 113: 832-836.
12. Marone G., Patella V., de Crescenzo G. et al.: Human heart mast cells in anaphylaxis and cardiovascular disease. Int. arch. Allergy Immunol. 1995, 107: 72-75.
13. Schwartz L.B.: Effector cells of anaphylaxis: mast cells and basophils. W: Anaphylaxis, G. Bock, J. Good. Chichester, United Kingdom: John Wiley & Sons, Ltd, 2004: 65-79.
14. Ditto A.M., Harris K.E., Krasnick J., Miller M.A., Patterson R.: Idiopathic anaphylaxis: a series of 335 cases. Ann. Allergy Asthma Immunol. 1996, 77: 85-291.
15. Kemp S.F., Lockey R.F., Wolf B.L., Lieberman P.: Anaphylaxis: a review of 266 cases. Arch. Intern. Med. 1995, 155: 1749-1754.
16. Brown S.G.A.: Clinical features and severity grading of anaphylaxis. J. Allergy Clin. Immunol. 2004, 114: 371-376.
17. Lockey R.F., Benedict L.M., Turkeltaub P.C. et al.: Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 1987, 79: 660-677.
18. Anderson J.: Cross reactivity to cephalosporins in patients allergic to penicillin. Pediatr. Infect. Dis. 1986, 5: 57-92.
19. Horan R. Sheffer A. Food-dependent exercise-induced anaphylaxis. Immunol. Allergy Clin. North. Am. 1991; 11: 757-766.
20. Lin R.Y., Schwartz L.B., Curry A. et al.: Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J. Allergy Clin. Immunol. 2000, 106: 65-71.
21. Yunginger J.W., Nelson D.R., Squillace D.L. et al.: Laboratory investigation of deaths due to anaphylaxis. J. Forensic Sci. 1991, 36: 857-865.
22. Kruszewski J.: Anafilaksja. Stanowisko panelu ekspertów Polskiego Towarzystwa Alergologicznego. Warszawa 2009: 55-63.
23. Sheikh A., Ten Broek V., Brown S.G., Simons F.E.: H1-antyhistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007, 62: 830-837.
24. Sheikh A., Shehata Y.A., Brown S.G., Simons F.E.: Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2009, 64: 204-212.
25. Choo K.J., Simons E.F., Sheikh A.: Glucocorticosteroids for the treatment of anaphylaxis. Cochrane Database Syst. Rev. 2010, 17: CD007596.
26. Kemp S.F., Lockey R.F., Simons F.E.: Epinephrine the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008, 63: 1061-1070.
27. Decker W.W., Campbell R.M., Manivannan V. et al.: The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology Project. J. Allergy Clin. Immunol. 2008, 122: 1161-5.
28. Simons E.F., Ardusso L.R., Bilo B. et al.: World Allergy Organization anaphylaxis guidelines: Summary. J. Allergy Clin. Immunol. 2011, 127: 587-93.
2. Yocum M.W., Butterfield J.H., Klein J.S. et al.: Epidemiology of anaphylaxis in Olmsted County: a population-based study. J. Allergy Clin. Immunol. 1999, 104: 452-456.
3. Lieberman P., Camargo C.A. Jr, Bohlke K., Jick H., Miller R.L., Sheikh A. et al.: Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann. Allergy Asthma Immunol. 2006, 97: 596-602.
4. Ewan P.: Anaphylaxis. BML 1996, 1998: 1442-1445, Wasserman S.I.: Anaphylaxis. Kaplan A.P.: Allergy. W.B. Saunders Comp. New York 1997: 565-572.
5. Mertes P.M., Laxenaire M.C., Alla F.: Groupe d’Etudes des Reactions Anaphylactoides Peranesthesiques: Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003, 99: 536-545.
6. Moss J.: Allergic to anesthetics. Anesthesiology 2003, 99: 521-523.
7. Graft D.F., Schuberth K.C., Kagey-Sobotka A. et al.: A prospective study of the natural history of large local reactions after Hymenoptera stings in children. J. Pediatr. 1984, 104: 664-668.
8. Müller U.R.: Insect sting allergy: clinical picture, diagnosis and treatment. Gustav Fischer Verlag, Stuttgart 1990.
9. Lieberman P.L.: Anaphylactoid reactions to radiocontrast material. Immunol. Allergy Clin. North. Am. 1992, 12: 649-652.
10. Ring J., Behrend H.: Anaphylaxis and anaphylactoid reactions: classification and pathophysiology. Clin. Rev. Allergy. Immunol. 1999, 17: 387-399.
11. Johansson S.G.O., Bieber T., Dahl R. et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 2004, 113: 832-836.
12. Marone G., Patella V., de Crescenzo G. et al.: Human heart mast cells in anaphylaxis and cardiovascular disease. Int. arch. Allergy Immunol. 1995, 107: 72-75.
13. Schwartz L.B.: Effector cells of anaphylaxis: mast cells and basophils. W: Anaphylaxis, G. Bock, J. Good. Chichester, United Kingdom: John Wiley & Sons, Ltd, 2004: 65-79.
14. Ditto A.M., Harris K.E., Krasnick J., Miller M.A., Patterson R.: Idiopathic anaphylaxis: a series of 335 cases. Ann. Allergy Asthma Immunol. 1996, 77: 85-291.
15. Kemp S.F., Lockey R.F., Wolf B.L., Lieberman P.: Anaphylaxis: a review of 266 cases. Arch. Intern. Med. 1995, 155: 1749-1754.
16. Brown S.G.A.: Clinical features and severity grading of anaphylaxis. J. Allergy Clin. Immunol. 2004, 114: 371-376.
17. Lockey R.F., Benedict L.M., Turkeltaub P.C. et al.: Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 1987, 79: 660-677.
18. Anderson J.: Cross reactivity to cephalosporins in patients allergic to penicillin. Pediatr. Infect. Dis. 1986, 5: 57-92.
19. Horan R. Sheffer A. Food-dependent exercise-induced anaphylaxis. Immunol. Allergy Clin. North. Am. 1991; 11: 757-766.
20. Lin R.Y., Schwartz L.B., Curry A. et al.: Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J. Allergy Clin. Immunol. 2000, 106: 65-71.
21. Yunginger J.W., Nelson D.R., Squillace D.L. et al.: Laboratory investigation of deaths due to anaphylaxis. J. Forensic Sci. 1991, 36: 857-865.
22. Kruszewski J.: Anafilaksja. Stanowisko panelu ekspertów Polskiego Towarzystwa Alergologicznego. Warszawa 2009: 55-63.
23. Sheikh A., Ten Broek V., Brown S.G., Simons F.E.: H1-antyhistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007, 62: 830-837.
24. Sheikh A., Shehata Y.A., Brown S.G., Simons F.E.: Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2009, 64: 204-212.
25. Choo K.J., Simons E.F., Sheikh A.: Glucocorticosteroids for the treatment of anaphylaxis. Cochrane Database Syst. Rev. 2010, 17: CD007596.
26. Kemp S.F., Lockey R.F., Simons F.E.: Epinephrine the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008, 63: 1061-1070.
27. Decker W.W., Campbell R.M., Manivannan V. et al.: The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology Project. J. Allergy Clin. Immunol. 2008, 122: 1161-5.
28. Simons E.F., Ardusso L.R., Bilo B. et al.: World Allergy Organization anaphylaxis guidelines: Summary. J. Allergy Clin. Immunol. 2011, 127: 587-93.